![]() PROCESS FOR PREPARING MICROCAPSULES OF CONTROLLED SIZE COMPRISING A PHOTOPOLYMERIZATION STEP
专利摘要:
The present invention relates to a process for the preparation of solid microcapsules comprising the following steps: a) the addition, with stirring, of a composition C1, comprising at least one active agent, in a photocrosslinkable polymeric composition C2, whereby an emulsion is obtained ( E1); b) addition with stirring of the emulsion (E1) in a composition C3, the viscosity of the composition C3 being greater than 2000 mPa.s at 25 ° C, whereby a double emulsion (E2) is obtained; c) applying shear to the emulsion (E2), said applied shear rate being less than 1000 s -1, whereby a double emulsion (E3) is obtained; and d) photopolymerizing the composition C2. 公开号:FR3059666A1 申请号:FR1661787 申请日:2016-12-01 公开日:2018-06-08 发明作者:Jamie WALTERS;Damien DEMOULIN 申请人:Calyxia SAS; IPC主号:
专利说明:
© Publication no .: 3,059,666 (to be used only for reproduction orders) ©) National registration number: 16 61787 ® FRENCH REPUBLIC NATIONAL INSTITUTE OF INDUSTRIAL PROPERTY COURBEVOIE © Int Cl 8 : C 08 F2 / 48 (2017.01), C 08 F2 / 22 A1 PATENT APPLICATION ©) Date of filing: 01.12.16. (© Applicant (s): CALYXIA Société par actions simpli- (© Priority: trusted - FR. @ Inventor (s): WALTERS JAMIE and DEMOULIN DAMIEN. 143} Date of public availability of the request: 08.06.18 Bulletin 18/23. ©) List of documents cited in the report preliminary research: Refer to end of present booklet (© References to other national documents ©) Holder (s): CALYXIA Simplified joint-stock company. related: ©) Extension request (s): (© Agent (s): LAVOIX. FR 3 059 666 - A1 164 / PROCESS FOR THE PREPARATION OF MICROCAPSULES OF CONTROLLED SIZE INCLUDING A PHOTOPOLYMERIZATION STEP. The present invention relates to a process for the preparation of solid microcapsules comprising the following steps: a) the addition, with stirring, of a composition C1, comprising at least one active ingredient, in a photocrosslinkable polymeric composition C2, whereby an emulsion (E1) is obtained; b) the addition, with stirring, of the emulsion (E1) into a composition C3, the viscosity of the composition C3 being greater than 2000 mPa.s at 25 ° C., whereby a double emulsion (E2) is obtained; c) applying a shear to the emulsion (E2), said applied shear rate being less than 1000 s ′ 1 , whereby a double emulsion (E3) is obtained; and d) photopolymerization of composition C2. PROCESS FOR THE PREPARATION OF CONTROLLED SIZE MICROCAPSULES INCLUDING A PHOTOPOLYMERIZATION STEP The present invention relates to a process for preparing microcapsules of controlled size comprising a photopolymerization step. In many industries, notably the chemical, cosmetic, agrochemical, paint or fuel and lubricant industries, it is important to encapsulate and isolate an active material from the surrounding medium, in order to protect the active against hydrolysis, thermal degradation, oxidation or other processes that can reduce the performance of the asset. In addition, many applications within these industries require that the capsules produced have a narrow size range typically in the micrometer range (especially between 0.1 pm and 20 pm) for example to have better control over their overall performance . The issue of isolating an asset from the surrounding environment to improve asset performance is a relatively new area for a number of industries. In most non-organic industries, performance losses associated with factors such as hydrolysis, thermal degradation, oxidation and cross-reactivity are resolved by increasing the concentration of the active ingredient to achieve the desired level of performance. , which increases the cost and also generates other problems associated with the product formed from such processes. In recent years, a large number of encapsulation processes have been developed and reported in the literature, including spray drying, solvent evaporation, interfacial polymerization and centrifugal extrusion among many others. However, for industrial-scale encapsulation processes, emulsion techniques dominate. Such methods use a step forming an emulsion of a hydrophobic oil or of a waxy phase, dispersed in an aqueous medium or alternatively an aqueous phase, dispersed in a hydrophobic oil or a waxy medium. The two phases are emulsified using either a homogenizer or an agitated container equipped with baffles and stabilized using surfactants, lipids or polymeric emulsifiers. Alternatively, a reaction at the interface between the two phases can be used to form a polymer shell. However, these systems produce emulsions and capsules which are polydisperse or too large (above 20 µm). In addition, these systems require the use of water to form one of the phases. They also require the use of surfactants or similar emulsifiers to stabilize the emulsion, which have the drawback of being able to react with the encapsulant or provide contaminants in the different phases. The present invention aims to provide capsules containing an active ingredient by the implementation of a mass process in order to satisfy the volumes to meet the demands of the non-organic industries. The present invention also aims to provide a double emulsion encapsulation process making it possible to obtain capsules of controlled size, in particular of size less than 20 μm, or even 5 μm. The present invention also aims to provide a method for encapsulating active agents which can be used in the absence of water and / or surfactants and emulsifiers. Thus, the present invention relates to a process for the preparation of solid microcapsules comprising the following steps: a) the addition, with stirring, of a composition C1, comprising at least one active ingredient, in a photocrosslinkable polymeric composition C2, the compositions C1 and C2 not being miscible with each other, whereby a emulsion (E1) comprising drops of composition C1 dispersed in composition C2; b) the addition, with stirring, of the emulsion (E1) in a composition C3, the compositions C2 and C3 not being miscible with each other, the viscosity of the composition C3 being greater than the viscosity of l emulsion (E1), and being greater than 2000 mPa.s at 25 ° C, whereby a double emulsion (E2) is obtained comprising drops dispersed in composition C3; c) applying a shear to the emulsion (E2), said applied shear rate being less than 1000 s 1 , whereby a double emulsion (E3) is obtained comprising drops of controlled size dispersed in the composition C3; and d) photopolymerization of composition C2, whereby solid microcapsules are obtained dispersed in composition C3. The process of the invention thus allows the production on an industrial scale of populations of double emulsion drops of controlled size and in particular less than 20 μm. The control of the size of the capsules obtained by the process of the invention is due in particular to the control of the viscoelasticity of the compositions C2 and C3. The process of the invention allows the production of capsules of controlled size by the implementation of a photopolymerization step, in particular of UV crosslinking, of the intermediate phase of the double emulsion. This photopolymerization step notably makes it possible to solidify the intermediate layer of the capsules and thus eliminates any coalescence. Preferably, the microcapsules obtained according to the method of the invention have an average diameter (as measured by optical microscopy or by TEM or by light scattering technique) of between 0.1 μm and 20 μm, and preferably between 1 pm and 20 pm. Step a) During step a), a composition C1 is added to a photocrosslinkable polymeric composition C2, this step being carried out with stirring, which means that the composition C2 is stirred, typically mechanically, while the composition C1 is added, and this in order to emulsify the mixture of compositions C1 and C2. The addition of composition C1 to composition C2 is typically carried out dropwise. During step a), the composition C1 is at a temperature between 0 ° C and 100 ° C, preferably between 10 ° C and 80 ° C, qlreferentially between 15 ° C and 60 ° C. During step a), the composition C2 is at a temperature between 0 ° C and 100 ° C, preferably between 10 ° C and 80 ° C, qlreferentially between 15 ° C and 60 ° C. Under the addition conditions of step a), the compositions C1 and C2 are not miscible with each other, which means that the quantity (by weight) of the composition C1 capable of being dissolved in composition C2 is less than or equal to 5%, preferably less than 1%, and preferably less than 0.5%, relative to the total weight of composition C2, and that the quantity (by weight) of composition C2 capable of to be dissolved in composition C1 is less than or equal to 5%, preferably less than 1%, and preferably less than 0.5%, relative to the total weight of composition C1. Thus, when the composition C1 comes into contact with the composition C2 with stirring, the latter is dispersed in the form of drops, called simple drops. The immiscibility between compositions C1 and C2 also makes it possible to avoid the migration of the active ingredient from composition C1 to composition C2. Composition C2 is stirred so as to form an emulsion comprising drops of composition C1 dispersed in composition C2. This emulsion is also called "simple emulsion" or C1-in-C2 emulsion. To implement step a), one can use any type of agitator usually used to form emulsions, such as for example a mechanical paddle stirrer, a static foam concentrate, an ultrasonic homogenizer, a membrane homogenizer, a homogenizer at high pressure, a colloid mill, a high shear disperser or a high speed homogenizer. Composition C1 Composition C1 comprises at least one active ingredient A. This composition C1 serves as a vehicle for active ingredient A in the process of the invention, in the drops formed during the process of the invention and in the solid capsules obtained. According to a first variant of the process of the invention, the composition C1 is monophasic, that is to say that it is pure active ingredient A or else a solution comprising active ingredient A in dissolved form . According to one embodiment, the active agent is dissolved in composition C1. According to this variant, composition C1 typically consists of a solution of the active ingredient A in an aqueous solution, or an organic solvent, or a mixture of organic solvents, the active ingredient A being present in a mass content of from 1% to 99 %, relative to the total mass of composition C1. Active ingredient A can be present according to a mass content ranging from 5% to 95%, from 10% to 90%, from 20% to 80%, from 30% to 70%, or from 40% to 60%, relative to the total mass of composition C1. According to one embodiment, composition C1 consists of active ingredient A. According to another embodiment of the invention, the composition C1 is a two-phase composition, which means that the active ingredient is dispersed, either in liquid form or in solid form, in the composition C1 and is not completely dissolved in said composition C1. According to one embodiment, the active agent is dispersed in the form of solid particles in composition C1. According to this embodiment, composition C1 can consist of a dispersion of solid particles of the active ingredient in an organic solvent or in a mixture of organic solvents. According to this embodiment, composition C1 can consist of a dispersion of solid particles of the active ingredient in an aqueous phase, which comprises water and optionally hydrophilic organic solvents. The active used is for example: - a crosslinking agent, a hardener, an organic or metallic catalyst (such as an organometallic or inorganometallic complex of platinum, palladium, titanium, molybdenum, copper, zinc) used to polymerize formulations of polymer, elastomer , rubber, paint, adhesive, sealant, mortar, varnish or coating; - a dye or pigment intended for formulations of elastomers, paint, coating, adhesive, joint, mortar, or paper; - a fragrance (within the meaning of the molecule list established by the International Fragrance Association (IFRA) and available on the website www.ifraorg.org) intended for detergents such as detergents, home care products, cosmetic and personal care products, textiles, paints, coatings; - an aroma, a vitamin, an amino acid, a protein, a lipid, a probiotic, an antioxidant, a pH corrector, a preservative for food compounds and animal feed; - a softener, a conditioner for detergents, detergents, cosmetics and personal care products. As such, the active ingredients which can be used are for example listed in US Patents 6,335,315 and US 5,877,145; - an anti-color alteration agent (such as an ammonium derivative), an anti-foaming agent (such as an alcohol ethoxylate, an alkylbenzene sulfonate, a polyethylene ethoxylate, an alkylethoxysulfate or alkylsulfate) intended for the products detergents and laundry and home care products; - a brightening agent, also called color activator (such as a stilbene derivative, a coumarin derivative, a pyrazoline derivative, a benzoxazole derivative or a naphthalimide derivative) intended for detergents, detergents, cosmetics and personal care products; - a biologically active compound such as an enzyme, a vitamin, a protein, a plant extract, an emollient agent, a disinfecting agent, an antibacterial agent, an anti-UV agent, a medicament intended for cosmetic and care products. person, to textiles. Among these biologically active compounds, mention may be made of: vitamins A, B, C, D and E, para-aminobenzoic acid, alpha hydroxy acids (such as glycolic acid, lactic acid, malic acid, tartaric or citric acid), camphor, ceramides, polyphenols (such as flavonoids, phenolic acid, ellagic acid, tocopherol, ubiquinol), hydroquinone, hyaluronic acid, l isopropyl isostearate, isopropyl palmitate, oxybenzone, panthenol, proline, retinol, retinyl palmitate, salicylic acid, sorbic acid, sorbitol, triclosan, tyrosine; - a disinfecting agent, an antibacterial agent, an anti-UV agent, intended for paints and coatings; - a fertilizer, a herbicide, an insecticide, a pesticide, a fungicide, a repellant or a disinfectant intended for agrochemicals; a flame retardant, also called a flame retardant, (such as a brominated polyol such as tetrabromobisphenol A, a halogenated or non-halogenated organophosphorus compound, a chlorinated compound, an aluminum trihydrate, an antimony oxide, a zinc borate , red phosphorus, melamine, or magnesium dihydroxide) for plastics, coatings, paints and textiles; A photonic crystal or photochromophore intended for paints, coatings and polymeric materials forming curved and flexible screens; - a product known to those skilled in the art under the name of phase change materials (PCM for Phase Change Materials) capable of absorbing or restoring heat when they undergo a phase change, intended for the storage of 'energy. Examples of PCMs and their applications are described in A review on phase change energy storage: materials and applications ”, Farid et al., Energy Conversion and Management, 2004, 45 (910), 1597-1615. Examples of PCM include molten aluminum phosphate salts, ammonium carbonate, ammonium chloride, cesium carbonate, cesium sulfate, calcium citrate, calcium chloride, l hydroxide, calcium oxide, calcium phosphate, calcium saccharate, calcium sulfate, cerium phosphate, iron phosphate, lithium carbonate, lithium sulfate, magnesium chloride , magnesium sulfate, manganese chloride, manganese nitrate, manganese sulfate, potassium acetate, potassium carbonate, potassium chloride, potassium phosphate, rubidium carbonate, rubidium, disodium tetraborate, sodium acetate, sodium bicarbonate, sodium bisulfate, sodium citrate, sodium chloride, sodium hydroxide, sodium nitrate, sodium percarbonate, sodium persulfate, sodium phosphate, sodium propionate m, sodium selenite, sodium silicate, sodium sulfate, sodium tellurate, sodium thiosulfate, strontium hydrophosphate, zinc acetate, zinc chloride, sodium thiosulfate, paraffinic hydrocarbon waxes, polyethylene glycols. Composition C2 Composition C2 is a photocrosslinkable composition, which means that it is a composition capable of polymerizing (crosslinking) to give a solid material, to form the polymerized envelope of the solid microcapsules of the invention. According to one embodiment, composition C2 is a liquid whose viscosity at 25 ° C is between 500 mPa.s and 100,000 mPa.s. The viscosity is measured using a Haake Rheostress ™ 600 rheometer equipped with a cone with a diameter of 60 mm and an angle of 2 degrees, and with a temperature regulation cell set at 25 ° C. The viscosity value is read for a shear rate equal to 10 s 1 . Preferably, the viscosity of composition C2 at 25 ° C is between 000 mPa.s and 50 000 mPa.s, preferably between 2 000 mPa.s and 25 000 mPa.s, and for example between 3 000 mPa.s and 15 000 mPa.s. Preferably, the viscosity of composition C2 is greater than the viscosity of composition C1. According to this embodiment, independently of the viscosity of the active agent or of its chemical properties, the kinetics of destabilization of the drops of the emulsion (E1) is significantly slow, which allows the envelope of the microcapsules to be polymerized. during step d) before the emulsion destabilizes. The polymerization, once completed, then provides thermodynamic stabilization. Thus, the relatively high viscosity of composition C2 ensures the stability of the emulsion (E1) obtained at the end of step a). Preferably, the interfacial tension between the compositions C1 and C2 is low. Typically, these interfacial tensions vary between 0 mN / m and 50 mN / m, preferably between 0 mN / m and 20 mN / m. The low interfacial tension between the compositions C1 and C2 also advantageously makes it possible to ensure the stability of the emulsion (E1) obtained at the end of step a). According to one embodiment, the ratio between the volume of composition C1 and the volume of composition C2 varies between 1:10 and 10: 1. Preferably, this ratio is between 1: 3 and 5: 1, preferably between 1: 3 and 3: 1. This ratio can be adapted to control the thickness of the envelope of the polymerized microcapsules. According to one embodiment, composition C2 comprises at least one monomer or polymer, at least one crosslinking agent and at least one photoinitiator. According to one embodiment, the composition C2 comprises from 50% to 99% by weight of monomer or polymer, or a mixture of monomers or polymers, relative to the total weight of the composition C2. According to one embodiment, the composition C2 comprises from 1% to 20% by weight of crosslinking agent or of a mixture of crosslinking agents, relative to the total weight of the composition C2. According to one embodiment, the composition C2 comprises from 0.1% to 5% by weight of photoinitiator or of a mixture of photoinitiators, relative to the total weight of the composition C2. According to one embodiment, composition C2 comprises from 0.001% to 70% by weight of crosslinking agent relative to the weight of said composition C2. According to the invention, the term “monomer” or “polymer” designates any base unit suitable for the formation of a solid material by polymerization, either alone or in combination with other monomers or polymers. These monomers can be chosen from monomers comprising at least one reactive function chosen from the group consisting of acrylate, methacrylate, vinyl ether, N-vinyl ether, mercaptoester, thiolene, siloxane, epoxy, oxetane, urethane, isocyanate and peroxide functions. In particular, the monomers can be chosen from the monomers carrying at least one of the reactive functions mentioned above and carrying in addition at least one function chosen from the group consisting of primary, secondary and tertiary alkylamine functions, quaternary amine functions, sulfate functions, sulfonate, phophate, phosphonate, carboxylate, hydroxyl, halogen, and mixtures thereof. The polymers used in composition C2 can be chosen from polyethers, polyesters, polyurethanes, polyureas, polyethylene glycols, polypropylene glycols, polyamides, polyacetals, polyimides, polyolefins, polysulphides and polydimethylsiloxanes, said polymers additionally carrying at least one reactive function chosen in the group consisting of the acrylate, methacrylate, vinyl ether, N-vinyl ether, mercaptoester, thiolene, siloxane, epoxy, oxetane, urethane, isocyanate and peroxide functions. Among the examples of such polymers, there may be mentioned, but not limited to, the following polymers: poly (2- (1-naphthyloxy) -ethyl acrylate), poly (2- (2naphthyloxy) -ethyl acrylate), poly (2 - (2-naphthyloxy) -ethyl methacrylate), polysorbitol dimethacrylate, polyacrylamide, poly ((2- (1-naphthyloxy) ethanol), poly (2- (2naphthyloxy) ethanol), poly (1-chloro-2,3-epoxypropane ), poly (n-butyl isocyanate), poly (N-vinyl carbazole), poly (N-vinyl pyrrolidone), poly (p-benzamide), poly (pchlorostyrene), poly (p-methyl styrene), poly (p- phenylene oxide), poly (p-phenylene sulfide), poly (N- (methacryloxyethyl) succinimide), polybenzimidazol, polybutadiene, polybutylene terephthalate, polychloro, polychloro trifluoro ethylene, polyether imide, polyether ketone, polyether sulfone, polyane66 isophthalamide), poly (methyl 2-acrylamido-2-methoxyaceate), poly (2acrylamido-2-methylpropanesulfonic acid), poly-mono-butyl maleate, polybutylmethacrylate, poly (N-tert-butylmet hacrylamide), poly (N-nbutylmethacrylamide), polycyclohexylmethacrylamide, poly (m-xylenebisacrylamide 2,3-dimethyl-1,3-butadiene, N, N-dimethylmethacrylamide), poly (n-butyl methacrylate), poly (cyclohexyl methacrylate) polyisobutyl methacrylate, poly (4cyclohexylstyrene), polycyclol acrylate, polycyclol methacrylate, polydiethyl ethoxymethylenemalonate, poly (2,2,2-trifluoroethyl methacrylate), poly (1,1,1trimethylolpropane trimethacrylate), polymethacrylate, poly (methacrylate) ), poly (isophthalic dihydrazine), isophthalic polyacid, polydimethyl benzilketal, epichlorohydrin, poly (3,3-ethyl-diethoxyacrylate), poly (3,3-dimethylacrylate), poly (ethyl vinyl ketone), poly (vinyl ethyl ketone), poly ( penten-3one), polyformaldehyde poly (diallyl acetal), polyfumaronitrile, polyglyceryl propoxy triacrylate, polyglyceryl trimethacrylate, polyglycidoxypropyltrimethoxysilane, polyglycidyl acrylate, poly (n-heptyl acrylate), poly (n-heptyl ester of acrylic acid) heptyl met hacrylate), poly (3-hydroxypropionitrile), poly (2-hydroxypropyl acrylate), poly (2-hydroxypropyl methacrylate), poly (N (methacryloxyethyl) phthalimide), poly (1,9-nonanediol diacrylate), poly (1,9nonanediol dimethacrylate), poly (N- (n-propyl) acrylamide), poly (orthophthalic acid), poly (isophthalic acid), poly (1,4-benzenedicarboxylic acid), poly (1,3-benzenedicarboxylic acid), poly (phthalic acid), poly (mono-2acryloxyethyl ester), poly terephthalic acid, phthalic polyanhydride, polyethylene glycol diacrylate, polyethylene glycol methacrylate, polyethylene glycol dimethacrylate, poly (isopropyl acrylate), polysorbitol pentaacrylene polyvinyl chloride, polyvinyl bromide -hexyl silylene), poly (di-n-propyl siloxane), polydimethyl silylene, polydiphenyl siloxane, polyvinyl propionate, polyvinyl triacetoxysilane, polyvinyl tris-tert-butoxysilane, polyvinyl butyral, polyvinyl alcohol, polyvinyl acetate, polyethylene vinyl poly (bisphenol-A polysulfone), poly (1,3-dioxepane), poly (1,3-dioxolane), poly (1,4-phenylene vinylene), poly (2,6-dimethyl-1A-phenylene oxide), poly (4-hydroxybenzoic acid), poly (4-methyl pentene-1), poly (4-vinyl pyridine), polymethylacrylonitrile, polymethylphenylsiloxane, polymethylsilmethylene, polymethylsilsesquioxane, poly (phenylsilsesquioxane), poly (pyromellitimide-1,4-diphenyl ether), polytetrahydrofene, polythetihydrophen oxide), polyacrylonitrile, polyether sulfone, polyethylene-co-vinyl acetate, poly (perfluorethylene propylene), poly (perfluoralkoxyl alkane), or poly (styrene-acrylonitrile). The term “crosslinking agent” means a compound carrying at least two reactive functions capable of crosslinking a monomer or a polymer, or a mixture of monomers or polymers, during its polymerization. The crosslinking agent can be chosen from molecules carrying at least two functions chosen from the group consisting of acrylate, methacrylate, vinyl ether, N-vinyl ether, mercaptoester, thiolene, siloxane, epoxy, oxetane, urethane, isocyanate and peroxide functions. As a crosslinking agent, we can notably mention: - diacrylates, such as 1,6-hexanediol diacrylate, 1,6-hexanediol dimethacrylate, polyethylene glycol dimethacrylate, 1,9-nonanediol dimethacrylate, 1,4-butanediol dimethacrylate, 2,2-bis (4 -methacryloxyphenyl) propane, 1,3-butanediol dimethacrylate, 1,10-decanediol dimethacrylate, bis (2-methacryloxyethyl) N, N'-1,9-nonylene biscarbamate, 1,4-butanediol diacrylate, ethylene glycol diacrylate, 1,5-pentanediol dimethacrylate, 1,4Phenylene diacrylate, allyl methacrylate, Ν, Ν'-methylenebisacrylamide, 2,2bis [4- (2-hydroxy-3-methacryloxypropoxy) phenyl] propane , tetraethylene glycol diacrylate, ethylene glycol dimethacrylate, diethylene glycol diacrylate, triethylene glycol diacrylate, triethylene glycol dimethacrylate, polyethylene glycol diglycidyl ether, Ν, Ν-diallylacrylamide, 2,2-bis [ 2-acryloxyethoxy) phenyl] propane, glycidyl methacrylate; - multifunctional acrylates such as dipentaerythritol pentaacrylate, 1,1,1-trimethylolpropane triacrylate, 1,1,1-trimethylolpropane trimethacrylate, ethylenediamine tetramethacrylate, pentaerythritol triacrylate, pentaerythritol tetraacrylate; - acrylates also having another reactive function, such as propargyl methacrylate, 2-Cyanoethyl acrylate, tricyclodecane dimethanol diacrylate, hydroxypropyl methacrylate, N-acryloxysuccinimide, N- (2Hydroxypropyl) methacrylamide, N- (3- aminopropyl) methacrylamide hydrochloride, N- (t-BOC-aminopropyl) methacrylamide, 2-aminoethyl methacrylate hydrochloride, monoacryloxyethyl phosphate, o-nitrobenzyl methacrylate, acrylic anhydride, 2- (tert-butylamino) ethyl methacrylate, Ν, iallydiallylacrylamide, glycidyl methacrylate, 2-hydroxyethyl acrylate, 4- (2acryloxyaéhoxy) -2-hydroxybenzophenone, N- (Phthalimidomethyl) acrylamide, cinnamyl methacrylate. By "photoinitiator" is meant a compound capable of fragmenting under the effect of light radiation. The photoinitiators which can be used according to the present invention are known in the art and are described, for example in Photoinitiators in the crosslinking of coatings, G. Li Bassi, Double Liaison - Chemistry of Paints, n ° 361, November 1985, p.34- 41; Industrial applications of photoinduced polymerization, Henri Strub, L'Actualité Chimique, February 2000, p.5-13; and Photopolymers: theoretical considerations and setting reaction, Marc, J.M. Abadie, Double Liaison - Chimie des Peintures, n ° 435-436, 1992, p.28-34. These photoinitiators include: α-hydroxyketones, such as 2-hydroxy-2-methyl-1-phenyl-1-propanone, sold for example under the names DAROCUR® 1173 and 4265, IRGACURE® 184, 2959, and 500 by the company BASF, and ADDITOL ® CPK by the company CYTEC; α-aminoketones, in particular 2-benzyl-2-dimethylamino-1- (4morpholinophenyl) -butanone-1, sold for example under the names IRGACURE® 907 and 369 by the company BASF; - the aromatic ketones sold for example under the name ESACURE® TZT by LAMBERTI; or the thioxanthones sold for example under the name ESACURE® ITX by LAMBERTI, and the quinones. These aromatic ketones most often require the presence of a hydrogen donor compound such as tertiary amines and in particular alkanolamines. Mention may in particular be made of the tertiary amine ESACURE® EDB marketed by the company LAMBERTI. - the α-dicarbonyl derivatives, the most common representative of which is benzyldimethyl ketal sold under the name IRGACURE® 651 by BASF. Other commercial products are marketed by LAMBERTI under the name ESACURE® KB1, and - the acylphosphine oxides, such as for example the bisacylphosphine oxides (BAPO) marketed for example under the names IRGACURE® 819, 1700, and 1800, DAROCUR® 4265, LUCIRIN® TPO, and LUCIRIN® TPO-L by the company BASF. Among the photoinitiators, mention may also be made of aromatic ketones such as benzophenone, phenylglyoxylates, such as the methyl ester of phenyl glyoxylic acid, oxime esters, such as [1- (43059666 phenylsulfanylbenzoyl) heptylideneamino] benzoate, sulfonium salts, iodonium salts and oxime sulfonates. According to one embodiment, the composition C2 may also comprise an additional monomer or polymer capable of improving the properties of the shell of the microcapsules and / or of giving new properties to the shell of the microcapsules. Among these additional monomers or polymers, mention may be made of monomers or polymers carrying a group sensitive to pH, temperature, UV or IR. These additional monomers or polymers can induce the rupture of the solid microcapsules and subsequently the release of their content, after stimulation via pH, temperature, UV or IR. These additional monomers or polymers can be chosen from monomers or polymers carrying at least one reactive function chosen from the group consisting of acrylate, methacrylate, vinyl ether, N-vinyl ether, mercaptoester, thiolene, siloxane, epoxy, oxetane, urethane functions, isocyanate and peroxide, and also bearing one of the following groups: - a hydrophobic group such as a fluorinated group, for example trifluoroethyl methacrylate, trifluoroethyl acrylate, tetrafluoropropyl methacrylate, pentafluoropropyl acrylate, hexafluorobutyl acrylate, or fluorophenyl isocyanate; - a group sensitive to pH such as primary, secondary or tertiary amines, carboxylic acids, phosphate, sulfate, nitrate, or carbonate groups; a group sensitive to UV or cleavable by UV (or photochromic group) such as the azobenzene, spiropyran, 2-diazo-1,2-naphthoquinone, onitrobenzylated, thiol, or 6-nitro-veratroyloxycarbonyl groups, for example poly (ethylene oxide) -block-poly (2-nitrobenzylmethacrylate), and other block copolymers, as described in particular in Liu et al., Polymer Chemistry 2013, 4, 3431-3443; - A group sensitive to IR or cleavable by IR such as o-nitrobenzyl or 2-diazo-1,2-naphthoquinone, for example the polymers described in Liu et al., Polymer Chemistry 2013, 4, 3431-3443; and - a temperature sensitive group such as poly (N-isopropylacrylamide). Step b) During step b), the emulsion (E1) obtained in step a) is added to a composition C3, this step being carried out with stirring, which means that the composition C3 is stirred, typically mechanically, while that the emulsion (E1) is added, in order to emulsify the mixture of compositions C1, C2 and C3. The addition of the emulsion (E1) in the composition C3 is typically carried out drop by drop. During step b), the emulsion (E1) is at a temperature between 15 ° C and 60 ° C. During step b), the composition C3 is a temperature between 15 ° C and 60 ° C. Under the conditions of addition of step b), the compositions C2 and C3 are not miscible with each other, which means that the quantity (by weight) of the composition C2 capable of being dissolved in composition C3 is less than or equal to 5%, preferably less than 1%, and preferably less than 0.5%, relative to the total weight of composition C3, and that the quantity (by weight) of composition C3 capable of 'to be dissolved in composition C2 is less than or equal to 5%, preferably less than 1%, and preferably less than 0.5%, relative to the total weight of composition C2. Thus, when the emulsion (E1) comes into contact with the composition C3 with stirring, the latter is dispersed in the form of drops, called double drops, the dispersion of these drops of emulsion (E1) in the continuous phase C3 being called emulsion (E2). Typically, a double drop formed during step b) corresponds to a single drop of composition C1 as described above, surrounded by an envelope of composition C2 which completely encapsulates said single drop. The double drop formed during step b) can also comprise at least two single drops of composition C1, said single drops being surrounded by an envelope of composition C2 which completely encapsulates said single drops. Thus, said double drops comprise a heart made up of one or more single drops of composition C1, and a layer of composition C2 surrounding said heart. The resulting emulsion (E2) is generally a double polydisperse emulsion (C1-in-C2-in-C3 emulsion or C1 / C2 / C3 emulsion), which means that the double drops do not have a clear size distribution in the emulsion (E2). The immiscibility between the compositions C2 and C3 makes it possible to avoid mixing between the layer of composition C2 and the composition C3 and thus ensures the stability of the emulsion (E2). The immiscibility between the compositions C2 and C3 also makes it possible to prevent the active ingredient of the composition C1 from migrating from the heart of the drops to the composition C3. To implement step b), it is possible to use any type of agitator usually used to form emulsions, such as for example a mechanical paddle stirrer, a static emulsifier, an ultrasonic homogenizer, a membrane homogenizer, a homogenizer at high pressure, a colloid mill, a high shear disperser or a high speed homogenizer. Composition C3 According to the invention, the viscosity of the composition C3 at 25 ° C is greater than the viscosity of the emulsion (E1) at 25 ° C. Preferably, the viscosity of the composition C3 at 25 ° C is between 3,000 mPa.s and 100,000 mPa.s, preferably between 5,000 mPa.s and 80,000 mPa.s, for example between 7,000 mPa.s and 70,000 mPa.s. According to this embodiment, given the very high viscosity of the continuous phase formed by composition C3, the speed of destabilization of the double drops of the emulsion (E2) is significantly slow compared to the duration of the process of the invention , which then provides kinetic stabilization of the emulsions (E2) and then (E3) until the polymerization of the capsule shell is completed. The capsules, once polymerized, are thermodynamically stable. Thus, the very high viscosity of the composition C3 ensures the stability of the emulsion (E2) obtained at the end of step b). Preferably, the interfacial tension between the compositions C2 and C3 is low. The low interfacial tension between the compositions C2 and C3 also advantageously makes it possible to ensure the stability of the emulsion (E2) obtained at the end of step b). According to one embodiment, the ratio between the volume of emulsion (E1) and the volume of composition C3 varies between 1:10 and 10: 1. Preferably, this ratio is between 1: 9 and 3: 1, preferably between 1: 9 and 1: 1. This ratio can be adapted in order to control the total amount of active material encapsulated among the resulting population of polymerized microcapsules. According to one embodiment, composition C3 comprises at least one branched polymer, preferably of molecular weight greater than 5,000 g.mol 1 , preferably between 10,000 g.mol ' 1 and 500,000 g.mol 1 , for example between 50,000 g.mol 1 and 300,000 g.mol 1 . By “branched polymer” (or branched polymer) is meant a polymer having at least one branching point between its two end groups, a branching point (also called branching point) being a point of a chain on which is fixed a side chain also called branch or hanging chain. Among the branched polymers, mention may, for example, be made of grafted or comb polymers, or even star polymers or dendrimers. According to one embodiment, composition C3 comprises at least one polymer of molecular weight greater than 5,000 g.mol 1 , preferably between 10,000 g.mol 1 and 500,000 g.mol 1 , for example between 50,000 g.mol 1 and 300,000 g.mol 1 . As the polymer which can be used in composition C3, mention may be made of the following compounds, used alone or else mixed together: - cellulose derivatives, such as cellulose ethers: methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, methyl hydroxyethyl cellulose, ethyl hydroxyethyl cellulose, carboxymethyl cellulose, hydroxypropyl cellulose or methyl hydroxypropyl cellulose; - polyacrylates (also called carbomers), such as polyacrylic acid (PAA), polymethacrylic acid (PMAA), poly (hydroxyethyl methacrylate) (pHEMA), poly (N-2-hydroxypropyl methacrylate) (pHPMA) ; - polyacrylamides such as poly (N-isopropylacrylamide) (PNIPAM); polyvinylpyrrolidone (PVP) and its derivatives; - polyvinyl alcohol (PVA) and its derivatives; - poly (ethylene glycol), poly (propylene glycol) and their derivatives, such as poly (ethylene glycol) acrylate / methacrylate, poly (ethylene glycol) diacrylate / dimethacrylate, polypropylene carbonate; - polysaccharides such as carrageenans, carob gums or tara gums, dextran, xanthan gums, chitosan, agarose, hyaluronic acids, gellan gum, guar gum, gum arabic, gum tragacanth , diutane gum, oat gum, karaya gum, ghatti gum, curdlan gum, pectin, konjac gum, starch; - protein derivatives such as gelatin, collagen, fibrin, polylysine, albumin, casein; - silicone derivatives such as polydimethylsiloxane (also called dimethicone), alkyl silicones, aryl silicones, alkyl aryl silicones, polyethylene glycol dimethicones, polypropylene glycol dimethicone; - waxes, such as diester waxes (alkanediol diesters, hydroxyl acid diesters), triester waxes (triacylglycerols, alkane-1,2-diol, ω-hydroxy acid and fatty acid triesters, esters hydroxymalonic acid, fatty acid and alcohol, triesters of hydroxyl acids, fatty acid and fatty alcohol, triesters of fatty acid, hydroxyl acid and diol) and polyester waxes (polyesters of Fatty acids). The fatty acid esters which can be used as waxes in the context of the invention are, for example, cetyl palmitate, cetyl octanoate, cetyl laurate, cetyl lactate, cetyl isononanoate, stearate cetyl, stearyl stearate, myristyl stearate, cetyl myristate, isocetyl stearate, glyceryl trimyristate, glyceryl tripalmitate, glyceryl monostearate or glyceryl and cetyl palmitate; fatty acids which can be used as waxes such as cerotic acid, palmitic acid, stearic acid, dihydroxystearic acid, behenic acid, lignoceric acid, arachidic acid, myristic acid, l lauric acid, tridecyclic acid, pentadecyclic acid, margaric acid, nonadecyclic acid, heneicosylic acid, tricosylic acid, pentacosylic acid, heptacosylic acid, montanic acid or l nonacosylic acid; - fatty acid salts, in particular aluminum fatty acid salts such as aluminum stearate, hydroxyl aluminum bis (2-ethylhexanoate); - isomerized jojoba oil; - hydrogenated sunflower oil; - hydrogenated coconut oil; hydrogenated lanolin oil; castor oil and its derivatives, in particular modified hydrogenated castor oil or the compounds obtained by esterification of castor oil with fatty alcohols; - polyurethanes and their derivatives; - styrenic polymers such as styrene butadiene; - polyolefins such as polyisobutene. According to one embodiment, composition C3 comprises solid particles such as clays, silicas and silicates. Mention may be made, as solid particles which can be used in composition C3, of clays and silicates belonging in particular to the category of phyllosilicates (also called sheet silicas). By way of example of silicate which can be used in the context of the invention, mention may be made of Bentonite, Hectorite, Attapulgite, Sepiolite, Montmorillonite, Saponite, Sauconite, Nontronite, Kaolinite, Talc , Sepiolite, Chalk. Synthetic fumed silicas can also be used. The clays, silicates and silicas mentioned above can advantageously be modified by organic molecules such as polyethers, ethoxylated amides, quaternary ammonium salts, long chain diamines, long chain esters, polyethylene glycols, polypropylene glycols. These particles can be used alone or mixed together. According to one embodiment, composition C3 comprises at least one polymer of molecular weight greater than 5,000 g.mol 1 and solid particles. Any mixture of the compounds mentioned above can be used. Step c) In step c), the emulsion (E2), consisting of polydisperse drops dispersed in a continuous phase, is subjected to shearing, for example in a mixer, at a low shearing speed, namely less than 1000 s ' 1 According to one embodiment, the shearing speed applied in step c) is between 10 s 1 and 1000 s 1 . Preferably, the shear rate applied in step c) is strictly less than 1000 s 1 . During step c), the emulsion (E2) is introduced into a mixer and is then subjected to a shear which results in the formation of a third emulsion, the emulsion (E3). This emulsion (E3) is chemically identical to the emulsion (E2) but it is made up of double monodisperse drops, and not polydisperse like (E2). Typically, the emulsion (E3) consists of a dispersion of double drops comprising a core consisting of one or more single drops of composition C1, and a layer of composition C2 surrounding said core, said double drops being dispersed in composition C3. The difference between the emulsion (E2) and the emulsion (E3) is the variation in size of the double drops: the drops of the emulsion (E2) are polydispersed in size while the drops of the emulsion (E3) are monodisperse thanks to the fragmentation mechanism taking place during step c). Emulsion drops (E2) can only be effectively fragmented into fine, monodisperse emulsion drops (E3) if a high shear stress is applied to them. The shear stress σ applied to a drop of emulsion (E2) is defined as the tangential force per unit of drop surface resulting from the macroscopic shear applied to the emulsion during its agitation during step c). The shear stress σ (expressed in Pa), the viscosity of the composition C3 η (expressed in Pa s) and the shear rate γ (expressed in s 1 ) applied to the emulsion (E2) during its stirring during from step c) are linked by the following equation: σ = ηγ Thus, the high viscosity of composition C3 makes it possible to apply a very high shear stress to the drops of emulsion (E2) in the mixer, even if the shear speed is low and the shear inhomogeneous. To carry out step c), any type of agitator usually used for forming emulsions can be used, such as, for example, a mechanical paddle stirrer, a static emulsifier, an ultrasonic homogenizer, a membrane homogenizer, a homogenizer. at high pressure, a colloid mill, a high shear disperser or a high speed homogenizer. According to a preferred embodiment, a simple foam concentrate is used such as a mechanical paddle stirrer or a static foam concentrate to implement step a). Indeed, this is possible because the method of the invention requires neither a controlled shear nor a shear greater than 1000 s 1 . Step d) Step d) consists in subjecting the emulsion (E3) to a photopolymerization, which will allow the photopolymerization of the composition C2. This step will make it possible to obtain microcapsules encapsulating the active ingredient as defined above. According to one embodiment, step d) consists in exposing the emulsion (E3) to a light source capable of initiating the photopolymerization of the composition C2. Preferably, the light source is a UV light source. According to one embodiment, the UV light source emits in the wavelength range between 100 nm and 400 nm. According to one embodiment, the emulsion (E3) is exposed to a light source for a duration of less than 15 minutes, and preferably for 5 to 10 minutes. During step d), the envelope of the above-mentioned double drops, made up of photocrosslinkable composition C2, is crosslinked and thus converted into a viscoelastic polymeric envelope, encapsulating and protecting the active agent from its release in the absence of a mechanical triggering. . The composition obtained at the end of step d), comprising solid microcapsules dispersed in composition C3, is ready for use and can be used without any additional step of post-treatment of the capsules being required. The thickness of the envelope of the microcapsules thus obtained is typically between 10 nm and 2.5 pm, preferably between 100 nm and 1000 nm. According to one embodiment, the solid microcapsules obtained at the end of step d) are devoid of water and / or surfactant. The process of the invention has the advantage of not requiring water, in any of the steps described. The process of the invention thus makes it possible to encapsulate water-sensitive compounds. The process of the invention has the advantage of not requiring a surfactant in any of the steps described. The process of the invention thus makes it possible to reduce the presence of additives which could modify the properties of the final product obtained after release of the active ingredient. EXAMPLES EXAMPLE 1 Preparation of Solid Microcapsules Using a Very Viscous C3 Phase and Low Shear This example demonstrates the use of a viscous C3 composition making it possible to obtain monodisperse capsules of size less than 20 μm even by applying very low shear to the double emulsion (E2). Composition of C1, C2 and C3: • Composition C1 is an alginate solution (active) at 5% by mass. • Composition C2 is a mixture of 69% by weight of polymer CN981 (polyacrylate oligomer from the brand Sartomer, Arkema); 30% by weight of hexanediol diacrylate (crosslinking agent) and 1% by weight of Darocure 1173 (photoinitiator). • Composition C3 is an alginate solution at 15% by mass, with a viscosity of 63,000 s 1 at 25 ° C. Manufacturing of microcapsules: A mechanical agitator (Heidolph RZR 2021) equipped with a deflocculating stirring propeller with a diameter of 3 cm is used to carry out all of the emulsification steps. Step a): composition C1 is added dropwise to composition C2 at a ratio C1: C2 = 30:70 by weight with stirring at 500 rpm. Step b): the emulsion (E1) obtained in the previous step is added dropwise to composition C3 at an E1: C3 ratio = 10:90 by weight with stirring at 500 rpm. Step c): the emulsion (E2) thus obtained is left under stirring at 500 rpm for 10 minutes. The shear applied by a stirring propeller is very little controlled. Under the conditions of step c) the shear applied to the emulsion (E2) can be estimated at less than 500 s 1 (for the calculation details, reference is made to: Metzner AB, Otto RE. Agitation of non Newtonian fluids. AlChE J (1957) 3: 3-10; Wu, J et al., Estimation of agitator flow shear rate. AlChE J (2006) 52: 2323-2332). Step d): the monodisperse emulsion (E3) thus obtained is irradiated for 10 minutes using a UV light source (Dymax LightBox ECE 2000) having a maximum light intensity of 0.1 W / cm 2 at a wavelength of 365 nm, to allow cross-linking of the capsules. The size distribution of the capsules thus obtained is measured by light scattering technique using a Mastersizer 3000 (Malvern Instruments) equipped with a Hydro SV dying cell. The average size of the capsules is measured at 26 µm. The width at mid-height of the size distribution (considered as a simple means of evaluating the monodispersity of the capsules) is measured at 31 μm. Example 2 Preparation of Solid Microcapsules Using a Very Viscous C3 Phase and High Shear This example demonstrates that with the same formulation as in Example 1, the application of high shear does not improve the monodispersity of the capsules obtained. In this example, an emulsion (E2) identical in all respects to that of Example 1 is first obtained. This is then separated into 2 fractions of equal volume which are introduced into a Couette type high shear cell manufactured by the company TSR33. This cell is made up of 2 concentric cylinders, one mobile and the other fixed, separated by a 100 µm air gap. The rotation of the movable cylinder makes it possible to apply uniform shear to all the emulsion contained in the air gap. The first fraction of the emulsion (E2) is subjected to a shear of 6,300 s 1 and the second fraction to a shear of 14,300 s 1 . The emulsions (E3) thus obtained are irradiated for 10 minutes using a UV light source (Dymax LightBox ECE 2000) having a maximum light intensity of 0.1 W / cm 2 at a wavelength of 365 nm, to allow cross-linking of the capsules. The size distribution of the capsules thus obtained is measured by light scattering technique using a Mastersizer 3000 (Malvern Instruments) equipped with a Hydro SV dying cell. The average size of the capsules and the width at half height of the size distribution obtained are summarized in the table below and compared with the values obtained in Example 1. It is clearly seen that the application of high shear does not not decrease the average size and monodispersity of the capsules. Example 1 Example 2 Shear <500 s 1 (pale deflocculating) 6,300 s 1 (Duvet cell) 14,300 s 1 (Duvet cell) Average height 5.0 pm 5.2 pm 5.8 pm Width at mid-heightof the distribution 5.5 pm 5.8 pm 6.8 pm Example 3 Preparation of Solid Microcapsules Using a Low Viscous C3 Phase and Different Shear Values This example demonstrates that when a C3 composition with a viscosity of less than 10 000 to 2000 mPa.s at 25 ° C. is used to manufacture microcapsules, it is necessary to resort to an additional step of high shear in order to obtain microcapsules of monodisperse size less than 20 pm. Composition of C1, C2 and C3: · The composition of C1 and C2 is identical to that of Example 1. • Composition C3 is an alginate solution at 5% by mass, with a viscosity of 1,500 mPa.s. Manufacturing of microcapsules: Steps a) and b) are carried out in an identical manner to those of Example 1. Step c): The emulsion (E2) obtained is separated into 3 fractions numbered 1, 2, and 3 of equal volume which are subjected to the following shearing conditions: Shear conditions Fraction 1 Pale deflocculator, shear <500 s 1 Fraction 2 Duvet cell, shear 6,300 s 1 Fraction 3 Duvet cell, shear 14,300 s 1 Step d): Fractions 1, 2, and 3 are irradiated for 10 minutes using a UV light source (Dymax LightBox ECE 2000) having a maximum light intensity of 0.1 W / cm 2 at a wavelength of 365 nm, to allow cross-linking of the capsules. The size distribution of the capsules thus obtained is measured by light scattering technique using a Mastersizer 3000 (Malvern Instruments) equipped with a Hydro SV dying cell. The average size of the capsules and the width at half height of the size distribution obtained are summarized in the table below. It is clearly seen that it is necessary to apply a shear of at least 6,300 s 1 in order to obtain monodisperse capsules of size less than 20 μm. Average height Width at mid-height ofthe distribution Fraction 1 26 pm 31 pm Fraction 2 4 pm 15 pm Fraction 3 12.5 pm 12 pm
权利要求:
Claims (10) [1" id="c-fr-0001] 1. Process for the preparation of solid microcapsules comprising the following steps: a) the addition, with stirring, of a composition C1, comprising at least one active ingredient, in a photocrosslinkable polymeric composition C2, the compositions C1 and C2 not being miscible with each other, whereby a emulsion (E1) comprising drops of composition C1 dispersed in composition C2; b) the addition, with stirring, of the emulsion (E1) in a composition C3, the compositions C2 and C3 not being miscible with each other, the viscosity of the composition C3 being greater than the viscosity of l emulsion (E1), and being greater than 2000 mPa.s at 25 ° C, whereby a double emulsion (E2) is obtained comprising drops dispersed in composition C3; c) applying a shear to the emulsion (E2), said applied shear rate being less than 1000 s 1 , whereby a double emulsion (E3) is obtained comprising drops of controlled size dispersed in the composition C3; and d) photopolymerization of composition C2, whereby solid microcapsules are obtained dispersed in composition C3. [2" id="c-fr-0002] 2. Method according to claim 1, wherein the composition C2 is a liquid whose viscosity at 25 ° C is between 500 mPa.s and 100,000 mPa.s. [3" id="c-fr-0003] 3. Method according to any one of claims 1 or 2, wherein the composition C2 comprises at least one monomer or polymer, at least one crosslinking agent and at least one photoinitiator. [4" id="c-fr-0004] 4. Method according to claim 3, wherein the composition C2 comprises from 0.001% to 70% by weight of crosslinking agent relative to the total weight of composition C2. [5" id="c-fr-0005] 5. Method according to any one of claims 1 to 4, in which the active agent is dissolved in composition C1 or is dispersed in the form of solid particles in composition C1. 5 [6" id="c-fr-0006] 6. Method according to any one of claims 1 to 5, wherein the composition C3 comprises at least one branched polymer, preferably of molecular weight greater than 5000 g.mol 1 , and / or at least one polymer of molecular weight greater than 5000 g.mol ' 1 , and / or solid particles such as silicates. [7" id="c-fr-0007] 7. Method according to any one of claims 1 to 6, in which the viscosity of the composition C3 at 25 ° C is between 1,000 mPa.s and 100,000 mPa.s. 15 [8" id="c-fr-0008] 8. Method according to any one of claims 1 to 7, wherein the shear rate applied in step c) is between 10 s ' 1 and 1000 s' 1 . [9" id="c-fr-0009] 9. Method according to any one of claims 1 to 8, in which step d) consists in exposing the emulsion (E3) to a light source capable of initiating The photopolymerization of composition C2. [10" id="c-fr-0010] 10. The method of claim 9, wherein the light source is a UV light source.
类似技术:
公开号 | 公开日 | 专利标题 EP3548529B1|2020-10-14|Process for preparing microcapsules of controlled size comprising a photopolymerization step WO2018172431A1|2018-09-27|Method for preparing capsules with improved retention properties and capsules obtained therefrom EP3600643A1|2020-02-05|Method for preparing capsules comprising at least one volatile compound and capsules obtained therefrom FR3059665B1|2019-07-26|PROCESS FOR THE PREPARATION OF MICROCAPSULES AND MICROPARTICLES OF CONTROLLED SIZE EP3624932A1|2020-03-25|Method for preparing biodegradable capsules and capsules obtained FR3064190A1|2018-09-28|PROCESS FOR PREPARING CAPSULES COMPRISING AT LEAST ONE WATER-SOLUBLE OR HYDROPHILIC SUBSTANCE AND CAPSULES OBTAINED WO2019076911A1|2019-04-25|Method for preparing capsules sensitive to ph or uv radiation and capsules obtained therefrom FR3064191A1|2018-09-28|PROCESS FOR PREPARING CAPSULES COMPRISING AT LEAST ONE WATER-SOLUBLE OR HYDROPHILIC SUBSTANCE AND CAPSULES OBTAINED AU2017367182B2|2022-03-17|Process for preparing microcapsules of controlled size comprising a photopolymerization step JP7010965B2|2022-02-10|A method for producing size-controlled microcapsules including a photopolymerization step. WO2018172430A2|2018-09-27|Method for producing capsules comprising at least one volatile compound, and resulting capsules FR3064189A1|2018-09-28|ENCAPSULATION OF REAGENTS FOR THE PREPARATION OF A BIOMATERIAL
同族专利:
公开号 | 公开日 JP2020500707A|2020-01-16| MX2019006345A|2019-11-07| ES2834874T3|2021-06-21| US20200094214A1|2020-03-26| CN110062779A|2019-07-26| BR112019011248A2|2019-10-15| US20190388861A1|2019-12-26| FR3059666B1|2019-05-17| WO2018100179A1|2018-06-07| EP3548529B1|2020-10-14| EP3548529A1|2019-10-09| CA3045215A1|2018-06-07| KR20190126048A|2019-11-08| US10850247B2|2020-12-01| CN110062779B|2021-12-31| AU2017367182A1|2019-06-20|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题 US20020160109A1|2000-12-13|2002-10-31|Yoon Yeo|Microencapsulation of drugs by solvent exchange| FR2867075A1|2004-03-03|2005-09-09|Ethypharm Sa|Monodisperse biodegradable microspheres, useful for administration of drugs, e.g. proteins or peptides, obtained from emulsion comprising polymer and aqueous phases by shearing and removing solvent|WO2020089129A1|2018-10-31|2020-05-07|Solvay Specialty Polymers Italy S.P.A.|Self-lubricating coating composition| WO2020089128A1|2018-10-31|2020-05-07|Solvay Specialty Polymers Italy S.P.A.|Curable composition of elastomers|AR006355A1|1996-03-22|1999-08-25|Procter & Gamble|BIODEGRADABLE SOFTENING ASSET AND CONTAINING COMPOSITION| BR9713263A|1996-10-21|2000-10-24|Procter & Gamble|Concentrated fabric softener composition| CN1816389A|2003-07-03|2006-08-09|Lg化学株式会社|Method for preparing microcapsule by miniemulsion polymerization| CN101362069B|2008-10-08|2011-06-01|中国科学院过程工程研究所|Hollow porous micro-capsule and preparation method thereof| CN102702449B|2012-06-13|2013-09-18|福建省锦浪精细化工有限公司|Preparation method of heat-resistant foamed microcapsule| EP3144058A1|2015-09-16|2017-03-22|Calyxia|Method for preparing microcapsules by double emulsion|US10793686B2|2018-12-07|2020-10-06|National Chung-Shan Institute Of Science And Technology|Preparation method of vinyl ester resin for optimizing heat-release during curing|
法律状态:
2017-11-17| PLFP| Fee payment|Year of fee payment: 2 | 2018-06-08| PLSC| Publication of the preliminary search report|Effective date: 20180608 | 2019-11-20| PLFP| Fee payment|Year of fee payment: 4 | 2020-11-18| PLFP| Fee payment|Year of fee payment: 5 | 2021-11-18| PLFP| Fee payment|Year of fee payment: 6 |
优先权:
[返回顶部]
申请号 | 申请日 | 专利标题 FR1661787|2016-12-01| FR1661787A|FR3059666B1|2016-12-01|2016-12-01|PROCESS FOR PREPARING MICROCAPSULES OF CONTROLLED SIZE COMPRISING A PHOTOPOLYMERIZATION STEP|FR1661787A| FR3059666B1|2016-12-01|2016-12-01|PROCESS FOR PREPARING MICROCAPSULES OF CONTROLLED SIZE COMPRISING A PHOTOPOLYMERIZATION STEP| AU2017367182A| AU2017367182B2|2016-12-01|2017-12-01|Process for preparing microcapsules of controlled size comprising a photopolymerization step| US16/466,001| US20190388861A1|2016-12-01|2017-12-01|Process with photopolymerization for preparing microcapsules of controlled size| CN201780074914.4A| CN110062779B|2016-12-01|2017-12-01|Process for the preparation of microcapsules of controlled size comprising a step of photopolymerization| JP2019549646A| JP7010965B2|2016-12-01|2017-12-01|A method for producing size-controlled microcapsules including a photopolymerization step.| BR112019011248A| BR112019011248A2|2016-12-01|2017-12-01|method for preparing solid microcapsules| MX2019006345A| MX2019006345A|2016-12-01|2017-12-01|Process for preparing microcapsules of controlled size comprising a photopolymerization step.| EP17818456.0A| EP3548529B1|2016-12-01|2017-12-01|Process for preparing microcapsules of controlled size comprising a photopolymerization step| CA3045215A| CA3045215A1|2016-12-01|2017-12-01|Process for preparing microcapsules of controlled size comprising a photopolymerization step| KR1020197018152A| KR20190126048A|2016-12-01|2017-12-01|Process for preparing microcapsules of controlled size comprising a photopolymerization step| PCT/EP2017/081227| WO2018100179A1|2016-12-01|2017-12-01|Process for preparing microcapsules of controlled size comprising a photopolymerization step| ES17818456T| ES2834874T3|2016-12-01|2017-12-01|Process for the preparation of microcapsules of controlled size that includes a photopolymerization step| US16/698,218| US10850247B2|2016-12-01|2019-11-27|Process with photopolymerization for preparing microcapsules of controlled size| 相关专利
Sulfonates, polymers, resist compositions and patterning process
Washing machine
Washing machine
Device for fixture finishing and tension adjusting of membrane
Structure for Equipping Band in a Plane Cathode Ray Tube
Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein an
国家/地区
|